CLOVIS ONCOLOGY INC's ticker is CLVS and the CUSIP is 189464100. A total of 184 filers reported holding CLOVIS ONCOLOGY INC in Q2 2015. The put-call ratio across all filers is 1.20 and the average weighting 0.6%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2019 | $145,000 | +163.6% | 13,929 | 0.0% | 0.06% | +178.3% |
Q3 2019 | $55,000 | -73.4% | 13,929 | 0.0% | 0.02% | -77.7% |
Q2 2019 | $207,000 | -40.2% | 13,929 | 0.0% | 0.10% | -43.7% |
Q1 2019 | $346,000 | -65.5% | 13,929 | +29.9% | 0.18% | -66.7% |
Q2 2017 | $1,004,000 | +344.2% | 10,724 | +201.7% | 0.55% | +381.6% |
Q1 2017 | $226,000 | -88.0% | 3,554 | -82.6% | 0.11% | -87.7% |
Q3 2015 | $1,880,000 | -6.8% | 20,441 | -11.0% | 0.93% | +21.7% |
Q2 2015 | $2,018,000 | +24.7% | 22,958 | -1.7% | 0.76% | +17.4% |
Q1 2014 | $1,618,000 | -35.8% | 23,358 | -38.0% | 0.65% | -55.2% |
Q2 2013 | $2,522,000 | – | 37,654 | – | 1.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Coppell Advisory Solutions LLC | 229 | $11,008 | 0.00% |